Trials / Recruiting
RecruitingNCT05945524
Analysis of the Resistance and Sensitivity Mechanisms to Teclistamab by Focusing on Single Immune Cell Examination
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 100 (estimated)
- Sponsor
- University Hospital, Toulouse · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to discover the immune and oncogenomic features that distinguish patients who respond to teclistamab from patients who are primarily resistant. Moreover, phenotypic and genotypic characteristics that occur with secondary resistance to teclistamab will be analyzed.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Bone marrow sampling | Bone marrow sampling collected at 12 weeks after initiation treatment (day 1 cycle 4) |
Timeline
- Start date
- 2023-09-28
- Primary completion
- 2026-03-31
- Completion
- 2026-05-31
- First posted
- 2023-07-14
- Last updated
- 2025-04-10
Locations
18 sites across 1 country: France
Source: ClinicalTrials.gov record NCT05945524. Inclusion in this directory is not an endorsement.